Unknown

Dataset Information

0

IGF2BP3 as a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma

ABSTRACT:

SUBMITTER: Hu F 

PROVIDER: S-EPMC12346309 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown CYP4B1 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma.
| S-EPMC7886130 | biostudies-literature
Unknown UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma
| S-EPMC12375651 | biostudies-literature
Unknown SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma.
| S-EPMC8217884 | biostudies-literature
Unknown Fibrinogen beta chain as a prognostic biomarker and therapeutic target in tobacco-associated lung adenocarcinoma.
| S-EPMC12583432 | biostudies-literature
Unknown NT5E (CD73) as a prognostic biomarker and therapeutic target associated with immune infiltration in lung adenocarcinoma.
| S-EPMC11799229 | biostudies-literature
Unknown Comprehensive analysis of KRT18 as a novel prognostic biomarker and potential target in lung adenocarcinoma.
| S-EPMC12401774 | biostudies-literature
Unknown AL365181.3 as a novel prognostic biomarker for lung adenocarcinoma.
| S-EPMC11836369 | biostudies-literature
Unknown TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma.
| S-EPMC11761590 | biostudies-literature
Unknown LRRC8A Is a Promising Prognostic Biomarker and Therapeutic Target for Pancreatic Adenocarcinoma.
| S-EPMC9688930 | biostudies-literature
Unknown SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma.
| S-EPMC5816374 | biostudies-literature